Search Results - V. V. Afanasyev
- Showing 1 - 5 results of 5
-
1
The Prospects of Succinates’ Use under Hypoxic Conditions in COVID-19 by Yu. Р. Orlov, V. V. Afanasyev, I. A. Khilenko
Published 2021-05-01
Article -
2
Success of Succinates and Prospects for Their Use in Critical Conditions by S. V. Sviridov, A. V. Butrov, V. V. Afanasyev, Yu. P. Orlov, A. Yu. Petrov
Published 2024-11-01
Article -
3
On the Possibility of Using Succinate in Hypoxia Developing in COVID-19 by Yu. P. Orlov, N. V. Govorova, O. V. Korpacheva, V. V. Afanasyev, I. A. Khilenko
Published 2021-07-01
Article -
4
Non-steroidal anti-inflammatory drugs for osteoarthritis and non-specific back pain: basic provisions for effective and safe use (Interdisciplinary consensus) by A. M. Lila, N. V. Zagorodniy, L. I. Alekseeva, V. V. Afanasyev, O. I. Butranova, I. V. Guryeva, D. A. Iskra, A. E. Karateyev, T. B. Minasov, A. P. Rachin, E. A. Taskina
Published 2024-12-01
Article -
5
Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders by A. M. Lila, V. A. Parfenov, A. E. Karateev, T. V. Adasheva, L. I. Alekseeva, V. V. Afanasyev, E. R. Barantsevich, O. V. Vorobyeva, O. S. Davydov, E. V. Ekusheva, A. I. Zagrebneva, D. A. Iskra, M. L. Kukushkin, A. P. Rachin, E. S. Filatova, M. V. Churyukanov, V. A. Shirokov
Published 2025-02-01
Article